Sustained release of microbicides by newly engineered vaginal rings
- 15 May 2009
- journal article
- basic science
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 23 (8), 917-922
- https://doi.org/10.1097/qad.0b013e32832af57c
Abstract
Objective: An effective vaginal microbicide against sexual HIV transmission remains elusive, with requirements for adherence to appropriate application of effective, nontoxic products being a major deterrent. We explored methods to enable sustained release of combinations of antiretroviral microbicides, utilizing intravaginal rings composed of biosoluble Acacia gum or nonbiodegradable hydrogel of 2-hydroxyethyl methacrylate and sodium methacrylate, materials approved for use by the US Food and Drug Administration. Design and methods: The reverse transcriptase inhibitors TMC120, PMPA, 3′-azido-3′-deoxythymidine, and a newly characterized anti-HIV agent, Boc-lysinated betulonic acid, were incorporated into vaginal rings with different combinations. Daily and cumulative release rates of these inhibitors in ring eluates were determined by high-performance liquid chromatography, gas chromatography, or immunoassay. Anti-HIV effects were measured by assessment of p24 Gag antigen in T-cell cultures exposed to HIV-1 isolates. Results: Drug release rates were sustained at concentrations higher than the minimum effective dose for HIV inhibition. The release was maintained for no less than 15 and 28 days from the Acacia gum and 2-hydroxyethyl methacrylate and sodium methacrylate rings, respectively. Boc-lysinated betulonic acid showed more than 90% inhibition of HIV-1 infection in H9 cells, with little toxicity to normal cells. Conclusion: The intravaginal rings described here are capable of efficacious drug delivery. Incorporation of several antiretroviral agents, including betulinol derivatives, which act at multiple levels of the HIV life cycle, may provide a synergistic effect to achieve higher efficacy on the inhibition of HIV infection.This publication has 25 references indexed in Scilit:
- Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agentsContraception, 2007
- Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicideInternational Journal of Pharmaceutics, 2006
- Boc-lysinated-betulonic acid: A potent, anti-prostate cancer agentBioorganic & Medicinal Chemistry, 2006
- Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the contextAIDS, 2006
- Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MSJournal of Chromatography B, 2006
- Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal ringsJournal of Antimicrobial Chemotherapy, 2005
- Keynote review: Progress in targeting HIV-1 entryDrug Discovery Today, 2005
- Emerging Drug Targets for Antiretroviral TherapyDrugs, 2005
- Sensitive determination of tenofovir in human plasma samples using reversed-phase liquid chromatographyJournal of Chromatography B, 2003
- A Simple Method for Improved Assay Demonstrates that HIV p24 Antigen Is Present as Immune Complexes in Most Sera from HIV-Infected IndividualsThe Journal of Infectious Diseases, 1990